SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,690.04 35.44
( 0.05%)

Global Indices

Nasdaq

51,626.09 -1,142.23
(-2.16%)

Dow Jones

7,338.46 -111.32
(-1.49%)

Hang Seng

61,006.88 -1,358.04
(-2.18%)

Nikkei 225

10,896.96 25.94
(0.24%)

Forex

USD-INR

95.71 -0.26
(-0.27%)

EUR-INR

108.89 -0.40
(-0.37%)

GBP-INR

127.22 -0.62
(-0.49%)

JPY-INR

0.58 0.00
(-0.38%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Amrutanjan Health Care Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

590006

INE098F01031

128.060531

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMRUTANJAN

23.16

1494.1

EPS(TTM)

Face Value()

Div & Yield %

22.31

0.95

Back

Global Vectra Helicorp reports standalone net loss of Rs 11.11 crore in the December 2025 quarter

Feb 14,2026

Net Loss of Global Vectra Helicorp reported to Rs 11.11 crore in the quarter ended December 2025 as against net loss of Rs 3.00 crore during the previous quarter ended December 2024. Sales rose 3.05% to Rs 146.93 crore in the quarter ended December 2025 as against Rs 142.58 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	146.93	142.58	3
OPM %	9.21	13.35	-
PBDT	4.21	12.88	-67
PBT	-16.20	-3.79	-327
NP	-11.11	-3.00	-270

77,690.04 35.44 ( 0.05%)

51,626.09 -1,142.23 (-2.16%)

7,338.46 -111.32 (-1.49%)

61,006.88 -1,358.04 (-2.18%)

10,896.96 25.94 (0.24%)

95.71 -0.26 (-0.27%)

108.89 -0.40 (-0.37%)

127.22 -0.62 (-0.49%)

0.58 0.00 (-0.38%)